Adicet Bio, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Adicet Bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2018 to Q1 2024.
  • Adicet Bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $111M.
  • Adicet Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $236K, a 99.4% decline from 2022.
  • Adicet Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $41.5M, a 82.9% decline from 2021.
  • Adicet Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $243M, a 79994% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $111M +$111M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 -$7K* +$1.13M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 -$1.13M -$146M -101% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $145M +$103M +245% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $42M -$4.82M -10.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $46.8M -$43.1M -47.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $89.9M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.